Ryan Specialty Quarterly report pursuant to Section 13 or 15(d)

Derivatives (Tables)

3 Months Ended

Mar. 31, 2024

The location and gains (losses) on derivatives are reported on the Consolidated Statements of Income as follows:


		Three Months Ended March 31,
	Income Statement Caption	2024			2023
Change in the fair value of the Deal-Contingent Forward	General and administrative	$	(2,482	)	$	—
Total impact of derivatives not designated as hedging instruments		$	(2,482	)	$	—

Interest rate cap premium amortization	Interest expense, net	$	(1,739	)	$	(1,739	)
Amounts reclassified out of other comprehensive income related to the interest rate cap	Interest expense, net		6,544			4,415
Total impact of derivatives designated as hedging instruments		$	4,805		$	2,676

The location and fair value of derivatives are reported on the Consolidated Balance Sheets as follows:


	Balance Sheet Caption	March 31, 2024		December 31, 2023
Derivatives not designated as hedging instruments
Deal-Contingent Forward	Accounts payable and accrued liabilities	$	3,334	$	852
Derivatives designated as hedging instruments
Interest rate cap	Other non-current assets	$	33,412	$	29,667